Beximco Pharmaceuticals (LON:BXP) Reaches New 52-Week High – Here’s Why

Beximco Pharmaceuticals Limited (LON:BXP)’s stock price hit a new 52-week high on Wednesday . The company traded as high as GBX 62.50 and last traded at GBX 60.75, with a volume of 53833 shares traded. The stock had previously closed at GBX 55.

Beximco Pharmaceuticals Stock Up 10.5%

The company has a debt-to-equity ratio of 5.27, a current ratio of 4.13 and a quick ratio of 0.37. The firm’s 50 day moving average price is GBX 52.12 and its two-hundred day moving average price is GBX 45.89. The firm has a market cap of £271.01 million, a price-to-earnings ratio of 0.03 and a beta of 0.25.

Beximco Pharmaceuticals Company Profile

Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.